One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene

被引:24
作者
Andreassen, Å [1 ]
Mollersen, L [1 ]
Vikse, R [1 ]
Steffensen, IL [1 ]
Mikalsen, A [1 ]
Paulsen, JE [1 ]
Alexander, J [1 ]
机构
[1] Natl Inst Publ Hlth, Dept Environm Med, N-0403 Oslo, Norway
关键词
neonatal; Min/+ mouse; multiple intestinal neoplasia; Apc gene; LOH; truncation mutations;
D O I
10.1016/S1383-5718(02)00065-7
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The C57BL/6J-Min/+ (multiple intestinal neoplasia) mouse has a heterozygous nonsense Apc(Min) (adenomatous polyposis coli) mutation, and numerous adenomas spontaneously develop in the intestine. Neonatal exposure of Min/+ mice to the food carcinogens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) (one injection of 50 mg/kg) increased the number of small intestinal tumours about three- and two-fold, respectively. The number of colonic tumours was only increased in males. We examined whether the wild-type Ape allele was affected in intestinal tumours induced by either PhIP or IQ. In spontaneously formed and in IQ-induced small intestinal and colonic tumours from these mice, the main mechanism for tumour induction was loss of wild-type Ape allele, i.e. loss of heterozygosity (LOH). In contrast to the IQ-induced (84% LOH) and spontaneously (88% LOH) formed tumours, only 55% of the PhIP-induced small intestinal tumours from males showed LOH. Tumours that apparently had retained the wild-type Ape allele were further analysed for the presence of truncated Ape proteins by the in vitro synthesised protein (IVSP) assay. Truncated Ape proteins, indicating truncation mutations in exon 15 of the Apc gene, were detected in two of the 12 PhIP-induced tumours in segment 2 (codons 686-1217), and two of five IQ-induced tumours, one in segment 2 and the other in segment 3 (codons 1099-1693). Three of these four mutations, all in segment 2 of the Ape gene, were confirmed by sequencing. The PhIP-induced mutations were detected at codon 1125 (C deletion) and 1130 (G-T transversion), and the IQ-induced mutation was at codon 956 (C-T transition). Importantly, no truncated proteins were detected in tumours from unexposed mice with apparently retained wild-type Ape allele. These results show that one injection of either PhIP or IQ induces intestinal tumours in the Min/+ mice by inactivation of the wild-type Ape allele either by causing LOH or truncation mutations. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:157 / 166
页数:10
相关论文
共 48 条
  • [1] Adamson RH, 1996, ARCH TOX S, V18, P303
  • [2] Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele
    Andreassen, Å
    Vikse, R
    Steffensen, IL
    Paulsen, JE
    Alexander, J
    [J]. MUTAGENESIS, 2001, 16 (04) : 309 - 315
  • [3] Boardman LA, 2001, GENE CHROMOSOME CANC, V30, P181, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1074>3.0.CO
  • [4] 2-K
  • [5] Mutational analysis of the liver, colon and kidney of Big Blue® rats treated with 2-amino-3-methylimidazo[4,5-f] quinoline
    Bol, SAM
    Horlbeck, J
    Markovic, J
    de Boer, JG
    Turesky, RJ
    Constable, A
    [J]. CARCINOGENESIS, 2000, 21 (01) : 1 - 6
  • [6] BROOKS RA, 1994, CANCER RES, V54, P1665
  • [7] MEAT, COOKING METHODS AND COLORECTAL-CANCER - A CASE-REFERENT STUDY IN STOCKHOLM
    DEVERDIER, MG
    HAGMAN, U
    PETERS, RK
    STEINECK, G
    OVERVIK, E
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 49 (04) : 520 - 525
  • [8] Edelmann W, 1999, CANCER RES, V59, P1301
  • [9] ENDO H, 1994, CANCER RES, V54, P3745
  • [10] INDUCTION OF LYMPHOMA IN CDF1 MICE BY THE FOOD MUTAGEN, 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE
    ESUMI, H
    OHGAKI, H
    KOHZEN, E
    TAKAYAMA, S
    SUGIMURA, T
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (12): : 1176 - 1178